CMR Surgical announced today that it received CE mark and UK approval for its Versius surgical robot in pediatric surgery.

CMR plans to begin US commercial activities for its Versius robots in 2026. Image credit: T. Schneider via Shutterstock.com. CMR Surgical has secured US Food and Drug Administration (FDA) clearance ...

CMR Surgical received the approval for abdominal surgery for its Versius platform in patients under age 18 in Europe, while SS Innovations will incorporate five new instruments into its SSi Mantra ...

CMR becomes the third surgical robotics company alongside Intuitive Surgical and SHURUI Robotics to obtain a CE mark in ...

CMR Surgical Ltd. hopes to soon gain U.S. FDA 510(k) clearance for its Versius Plus surgical robotic system to bring it to the U.S. market amid rising demand for robotic surgery. Although the ...

CMR Surgical receives CE Mark for use of Versius in paediatric surgery Small, modular design of the Versius system supports use in robotic-assisted paediatric surgery Cambridge, UK – 8 January 2026, ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

The good news keeps on coming for Cambridge-based global surgical robotics business, CMR Surgical. Hot on the heels of ...

CMR Surgical Ltd. secured more than $200 million in funding to bring its surgical robotic system, Versius, to the U.S. market and expand elsewhere. The financing, which came in the form of equity and ...

Opinions expressed by Digital Journal contributors are their own. The rise of robotic surgery in colorectal care marks a significant shift in modern medicine. With advancements in technology, surgeons ...

Small, modular design of the Versius system supports use in robotic-assisted paediatric surgery Cambridge, UK – 8 January ...